Monday, 15 September 2014

ScHARRNews - Monday15th & Tuesday 16th September 2014



Latest journal articles from HEDS
Published in July….Systematic review, network meta-analysis and exploratory cost-effectiveness model of randomized trials of minimally invasive techniques versus surgery for varicose veins Carroll C, Hummel S, Leaviss J, Ren S, Stevens JW, Cantrell A, Michaels JBritish Journal of Surgery 101(9):1040-1052 Aug 2014Societal Preferences for Distributive Justice in the Allocation of Health Care Resource
Alternative Telecare Idea...
MyFly - a type of telecare that it different to any other. Myfly could be worn as a watch, used in emergency situation and can even be used for "estimating a person's health condition".Intrigued? Click here to watch a brief clip! 


A critical review of the empirical evidence on alcohol availability in the UK policy context
There have been repeated calls for public health to play a greater role in the UK’s licensing system for alcohol outlets. New research from ScHARR’s Alcohol Research Group takes a critical look at the evidence behind those calls and the difficulties of translating evidence into policy in this area. Read the full paper (£0) at Photo by L
Lego play is a serious business!
When? Tuesday 9thSeptember, 2014 What? TaCT researchers Dr Jack Parker and Lauren Powell and a designer, Dr Matt Dexter, ran a workshop with paediatric physiotherapists to understand how the SMART Shoe might be used to empower children and young people and their parents to self-manage rehabilitation after receiving Botox Therapy. Where? Ryegate Children’s centre.To try and develop a research proje
Talking therapies can harm too – here's what to look out for - Medical Xpress
Medical XpressTalking therapies can harm too – here's what to look out forMedical XpressCognitive behaviour therapy challenges faulty thinking patterns that cause people to view themselves, their future and the world negatively. Credit: Fox valley Institute/Flickr, CC BY. People seeking therapy should always talk to a practitioner who ...

SEP 13

SEP 12

NICE trastuzumab emtansine appeal
From the NICE website:“NICE has received one appeal against the Final Appraisal Determination on the above technology from the following organisations:    Roche Products”More work for Hazel Squires, Emma Simpson, John Stevens, Helen Buckley Woods and Matt Stevenson here in HEDS?
EMA and FDA data consultations
AllTrials are currently urging people to respond to two ongoing consultations relating to patient data collected in trials.  It was posted on their website on the 11th September, with a closing date of 15th September.  Better research is certainly needed.

No comments:

Post a Comment